Alison Tree was appointed as a consultant clinical oncologist at the Royal Marsden hospital in 2014, specialising in urological malignancies. She holds an Associate honorary faculty position at the Institute of Cancer Research. Her MD thesis was on stereotactic radiotherapy techniques for prostate and oligometastatic cancer.
She is on the NCRI Prostate CSG, CTRad and UK SABR consortium committees, is CI of the TRAP and PRISM studies and co-investigator of the PACE, CORE, PIVOTALboost, DELINEATE and InPACT trials. Her research has received funding from Prostate Cancer UK, Cancer Research UK, the Rosetrees Trust, the JP Moulton foundation and Elekta. She is prostate lead for the MR Linac consortium. Her current research interests include technical radiotherapy improvements in prostate cancer, combination of systemic agents with radiotherapy and oligometastatic disease.

Dr. Cihan Gani is a radiation oncologist and clinician scientist at the Department of Radiation Oncology at the University Hospital Tübingen/Germany. He completed his medical studies at the University of Tübingen and Warren Alpert Medical school at Brown University, Providence Rhode Island. In 2013/2014 he joined Prof. Bristow research group at Princess Margaret Cancer Center as a post-doctoral research fellow of the German Cancer Aid.
He is the PI of the ongoing CAO/ARO/AIO-16 organ preservation trial of the German Rectal Cancer Study Group and was recently awarded with the “ARO – Young Investigator Award”. His research focus lies in the development of novel and innovative study protocols for patients with gastrointestinal malignancies and online MR-guided radiotherapy.